Tianjiao J. Lai
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Endometrial mesonephric-like adenocarcinoma: Clinicopathologic features, treatment, and outcomes.
Journal: Biomolecules & biomedicine
Published: July 23, 2025
Polystyrene nanoplastics induce ovarian injury by PI3K-Akt pathway-driven macrophage extracellular trap formation.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: July 05, 2025
Megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early-stage endometrial adenocarcinoma: a prospective study
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: December 02, 2024
Prognosis and fertility of stage II to IV borderline ovarian tumors after fertility-sparing surgery.
Prognosis and fertility of stage II to IV borderline ovarian tumors after fertility-sparing surgery.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 14, 2024
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer: a retrospective study.
Journal: Frontiers in oncology
Published: October 05, 2024
OTUD4-mediated inhibition of YAP1 signaling pathway in ovarian cancer: Implications for macrophage polarization and recruitment.
Journal: International immunopharmacology
Published: September 29, 2024
Oncological and reproductive outcomes after fertility-sparing surgery in patients with stage Ⅱ-Ⅲ borderline ovarian tumor
Journal: Zhonghua fu chan ke za zhi
Published: September 23, 2024
TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway.
Journal: Journal of translational medicine
Published: September 09, 2024
Role of non‑coding RNA intertwined with the Wnt/β‑catenin signaling pathway in endometrial cancer (Review).
Journal: Molecular medicine reports
Published: December 03, 2022
Identification of a novel pyridine derivative with inhibitory activity against ovarian cancer progression in vivo and in vitro.
Journal: Frontiers in pharmacology
Published: October 08, 2022
Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway.
Journal: Cell cycle (Georgetown, Tex.)
Published: April 11, 2022
Expression of MCMs in Endometrial Cancer and its Biological Correlation Analysis.
Journal: Combinatorial chemistry & high throughput screening
Published: November 26, 2021
Last Updated: 09/26/2026